3 results match your criteria: "Servicio de Medicina Intensiva. Hospital Universitario de Getafe[Affiliation]"
Frailty in severe COVID-19 survivors after ICU admission. A prospective and multicenter study in Mexico.
Med Intensiva (Engl Ed)
July 2024
Servicio de Medicina Intensiva. Hospital Universitario de Getafe, Madrid, Spain. CIBER de Enfermedades Respiratorias, CIBERES, Spain.
Objective: To analyze the presence of frailty in survivors of severe COVID-19 admitted in the Intensive Care Unit (ICU) and followed six months after discharge.
Design: An observational, prospective and multicenter, nation-wide study.
Setting: Eight adult ICU across eight academic acute care hospitals in Mexico.
Multidisciplinary Consensus on the Management of Non-Invasive Respiratory Support in the COVID-19 Patient.
Arch Bronconeumol
May 2024
Servicio de Neumologia, Hospital Universitario de Araba, Spain.
Article Synopsis
- * Key aspects of managing severe cases include deciding when to start non-invasive support, recognizing treatment failures, and implementing palliative or de-escalation strategies when improvement happens.
- * The document compiles insights from four scientific societies and 25 experts to enhance care approaches for severe COVID-19, reflecting on recent evidence rather than old guidelines from acute respiratory distress syndrome.
Temperature management in acute brain injury: A narrative review.
Med Intensiva (Engl Ed)
June 2024
Servicio de Medicina Intensiva. Hospital Universitario de Getafe, Getafe, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain; Departamento de Bioingeniería, Universidad Carlos III de Madrid, Leganés, Madrid, Spain; Departamento de Medicina, Universidad Europea de Madrid, Villaviciosa de Odón, Madrid, Spain.
Temperature management has been used in patients with acute brain injury resulting from different conditions, such as post-cardiac arrest hypoxic-ischaemic insult, acute ischaemic stroke, and severe traumatic brain injury. However, current evidence offers inconsistent and often contradictory results regarding the clinical benefit of this therapeutic strategy on mortality and functional outcomes. Current guidelines have focused mainly on active prevention and treatment of fever, while therapeutic hypothermia (TH) has fallen into disuse, although doubts persist as to its effectiveness according to the method of application and appropriate patient selection.
View Article and Find Full Text PDF